<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">372</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2020-28-s1-803-809</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>Drug turnover in the Russian Federation: customs aspect</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Timchenko</surname><given-names>T. N.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tonkonog</surname><given-names>V. V.</given-names></name><bio></bio><email>vikatonkonog79@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pogarskaya</surname><given-names>A. S.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Golovan</surname><given-names>T. V.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Konfino</surname><given-names>K. V.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Admiral F. F. Ushakov State Maritime University</aff><pub-date date-type="epub" iso-8601-date="2020-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2020</year></pub-date><volume>28</volume><fpage>803</fpage><lpage>809</lpage><history><pub-date date-type="received" iso-8601-date="2021-04-06"><day>06</day><month>04</month><year>2021</year></pub-date></history><permissions><copyright-statement>Copyright © 2020,</copyright-statement><copyright-year>2020</copyright-year></permissions><abstract>The current state of the Russian pharmaceutical market, its potential and development trends are significant for the state. The medical industry is strategically important, requiring efforts in its maintenance and development, which is reduced to reducing dependence on imported goods and origin. But at the same time, full import substitution in this industry is out of the question. In the context of global globalization and the current state of Affairs, the exchange of experience and medicines as its results is extremely important and relevant. Compliance with customs legislation when importing goods to the territory of the EEU is a fundamental principle of foreign economic activity, including medicines. The article analyzes the procedure for moving medicines, taking into account legislative innovations.</abstract><kwd-group xml:lang="en"><kwd>medicines</kwd><kwd>licensing controls</kwd><kwd>labelling</kwd><kwd>prohibitions and restrictions</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лекарственные средства</kwd><kwd>лицензионный контроль</kwd><kwd>маркировка</kwd><kwd>запреты и ограничения</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Аналитика. Аналитическая компания «RNC PHARMA». Режим доступа: https://rncph.ru (дата обращения 21.04.2020).</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Государственное регулирование: барьеры или стимулы для развития рынка? Deloitte. Режим доступа: https://www2.deloitte. com/content/dam/Deloitte/ru/Documents/life-sciences-health-care/russian/russian-pharmaceutical-market-trends-2019.pdf (дата обращения 21.04.2020).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Мониторинг фармацевтического рынка. DSM Group. Режим доступа: https://www.dsm.ru (дата обращения 21.04.2020).</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Статистика ФТС России. Официальный сайт ФТС России. Режим доступа: https://www.customs.ru (дата обращения 21.04.2020).</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Обзоры рынков. Adindex.ru. Режим доступа: https://adindex.ru/specprojects/market-6/pharmaceutical-market/index.phtml (дата обращения 21.04.2020).</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Нормативно-правовая база КонсультантПлюс. Режим доступа: http://www.consultant.ru (дата обращения 21.04.2020).</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Thomas JR. Compulsory licensing of patented inventions. Cong. Research Serv. 2014;R43266, Режим доступа: http://www.ipmall.info/sites/default/files/hosted_resources/crs/R43266_140114.pdf (дата обращения 22.04.2020).</mixed-citation></ref></ref-list></back></article>
